Prophylaxis and Management of Secondary CNS Lymphoma

被引：0
|
作者：
Roschewski, Mark [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
CNS prophylaxis; secondary CNS lymphoma; diffuse large B-cell lymphoma; STEM-CELL TRANSPLANTATION; NERVOUS-SYSTEM LYMPHOMA; HIGH-DOSE METHOTREXATE; PHASE-II; RELAPSE; INVOLVEMENT; RISK; CHEMOTHERAPY; RITUXIMAB; IBRUTINIB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXABS-107-
引用
收藏
页码：S10 / S15
页数：6
相关论文
共 50 条
  • [31] A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma
    Habringer, Stefan
    Demel, Uta M.
    Fietz, Anne-Katrin
    Lammer, Felicitas
    Schroers, Roland
    Hofer, Silvia
    Bairey, Osnat
    Braess, Jan
    Meier-Stiegenj, Anna Sofia
    Stuhlmann, Reingard
    Schmidt-Hieber, Martin
    Hoffmannm, Johannes
    Zinngrebe, Bettina
    Kaiser, Ulrich
    Reimer, Peter
    Moehle, Robert
    Fix, Peter
    Hoeffkes, Heinz-Gert
    Langenkamp, Ulrich
    Bueschenfelde, Christian Meyer zum
    Hopfer, Olaf
    Stoltefuss, Andrea
    La Rosee, Paul
    Blasberg, Henning
    Jordan, Karin
    Kaun, Stephan
    Meurer, Anna
    Unteroberdoerster, Meike
    von Bruenneck, Ann-Christin
    Capper, David
    Heppner, Frank L.
    Chapuy, Bjoern
    Janz, Martin
    Schwartz, Stefan
    Konietschke, Frank
    Vajkoczy, Peter
    Korfel, Agnieszka
    Keller, Ulrich
    EUROPEAN JOURNAL OF CANCER, 2024, 196
  • [32] Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma
    Kansara, Roopesh
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (11)
  • [33] Present and future treatment options for primary CNS lymphoma
    Citterio, Giovanni
    Reni, Michele
    Ferreri, Andres Jose Maria
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (17) : 2569 - 2579
  • [34] Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort study
    Tolley, Elisabeth Reuben
    Nielsen, Torsten Holm
    Hersby, Ditte Stampe
    Ostergaard, Simon
    Rasmussen, Malin
    Clausen, Michael Roost
    Al-Mashhadi, Ahmed Ludvigsen
    Egeberg, Karina Moeslund
    Haunstrup, Laura Mors
    Brieghel, Christian
    Niemann, Carsten Utoft
    El-Galaly, Tarec Christoffer
    Pedersen, Lars Moller
    BLOOD ADVANCES, 2025, 9 (04) : 893 - 905
  • [35] Primary CNS lymphoma: update on molecular pathogenesis and therapy
    Mo, Shirley S.
    Cleveland, Joseph
    Rubenstein, James L.
    LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 57 - 65
  • [36] Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
    Seidel, Clemens
    Viehweger, Christine
    Kortmann, Rolf-Dieter
    CANCERS, 2021, 13 (11)
  • [37] Outcomes of high-dose methotrexate for CNS prophylaxis in diffuse large B-cell lymphoma with an intermediate or high CNS-International Prognostic Index: A single-center retrospective cohort study
    Al-Mansour, Mubarak
    Absi, Ahmed
    Al-Mufti, Roula
    Alahmadi, Majed
    El-Hemaidi, Ihab
    Alamoudi, Sameer
    Eldadah, Saleem
    Aga, Syed Sameer
    Khan, Muhammed A.
    Alsaeed, Ahmed
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 17 (06)
  • [38] Secondary CNS lymphoma: the poisoned needle in the haystack
    Ferreri, A. J. M.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2335 - 2337
  • [39] Progress in primary CNS lymphoma
    O'Brien, Peter C.
    Seymour, John F.
    LANCET, 2009, 374 (9700) : 1477 - 1478
  • [40] Primary CNS lymphoma - an update
    Soussain, Carole
    Houillier, Caroline
    Choquet, Sylvain
    Hoang-Xuan, Khe
    BULLETIN DU CANCER, 2014, 101 (03) : 314 - 324
12345